Correction to: A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY tract cancers (BTC) at high risk for recurrence: PURITY study

Monica Niger; Federico Nichetti; Lorenzo Fornaro; Chiara Pircher; Federica Morano; Federica Palermo; Lorenza Rimassa; Tiziana Pressiani; Rossana Berardi; Andrea Casadei Gardini; Elisa Sperti; Lisa Salvatore; Davide Melisi; Francesca Bergamo; Salvatore Siena; Stefania Mosconi; Rafaella Longarini; Giuseppina Arcangeli; Salvatore Corallo; Laura Delliponti; Stefano Tamberi; Elena Fea; Giovanni Brandi; Ilario Giovanni Rapposelli; Massimiliano Salati; Paolo Baili; Rosalba Miceli; Silva Ljevar; Ilaria Cavallo; Elisa Sottotetti; Antonia Martinetti; Michele Droz Dit Busset; Carlo Sposito; Maria Di Bartolomeo; Filippo Pietrantonio; Filippo de Braud; Vincenzo Mazzaferro

doi:10.1186/s12885-024-12328-0

Correction to: A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY tract cancers (BTC) at high risk for recurrence: PURITY study

BMC Cancer. 2024 May 6;24(1):563. doi: 10.1186/s12885-024-12328-0.

Authors

Monica Niger¹, Federico Nichetti^{2

3}, Lorenzo Fornaro⁴, Chiara Pircher², Federica Morano², Federica Palermo², Lorenza Rimassa^{5

6}, Tiziana Pressiani⁶, Rossana Berardi⁷, Andrea Casadei Gardini^{8

9}, Elisa Sperti¹⁰, Lisa Salvatore^{11

12}, Davide Melisi^{13

14}, Francesca Bergamo¹⁵, Salvatore Siena^{16

17}, Stefania Mosconi¹⁸, Rafaella Longarini¹⁹, Giuseppina Arcangeli²⁰, Salvatore Corallo²¹, Laura Delliponti⁴, Stefano Tamberi²², Elena Fea²³, Giovanni Brandi²⁴, Ilario Giovanni Rapposelli²⁵, Massimiliano Salati²⁶, Paolo Baili²⁷, Rosalba Miceli²⁸, Silva Ljevar²⁸, Ilaria Cavallo²⁹, Elisa Sottotetti², Antonia Martinetti², Michele Droz Dit Busset³⁰, Carlo Sposito^{17

30}, Maria Di Bartolomeo², Filippo Pietrantonio², Filippo de Braud^{2

17}, Vincenzo Mazzaferro^{17

30}

Affiliations

¹ Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Via G. Venezian, 1, Milan, 20133, Italy. Monica.niger@istitutotumori.mi.it.
² Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Via G. Venezian, 1, Milan, 20133, Italy.
³ Computational Oncology, Molecular Diagnostics Program, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), Heidelberg, Germany.
⁴ Medical Oncology Unit, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
⁵ Department of Biomedical Sciences, Pieve Emanuele (Milan), Humanitas University, Milan, Italy.
⁶ Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.
⁷ Clinica Di Oncologia Medica, A.O.U. Delle Marche, Università Politecnica Delle Marche, Ancona, Italy.
⁸ Vita-Salute San Rafaele University, Milan, Italy.
⁹ Department of Medical Oncology, San Rafaele Scientifc Institute IRCCS, Milan, Italy.
¹⁰ Department of Oncology, University of Turin, AO Ordine Mauriziano Hospital, Turin, Italy.
¹¹ Oncologia Medica, Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 11Oncologia Medica, Rome, Italy.
¹² Oncologia Medica, Università Cattolica del Sacro Cuore, Rome, Italy.
¹³ Molecular Clinical Oncology Research Unit, Università Degli Studi Di Verona, Verona, Italy.
¹⁴ Investigational Cancer Therapeutics Clinical Unit, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.
¹⁵ Medical Oncology 1 Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
¹⁶ Department of Hematology Oncology, and Molecular Medicine, Grande Ospedale Metropolitano Niguarda, Milan, Italy.
¹⁷ Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
¹⁸ Medical Oncology Unit, Giovanni XXIII Hospital, Bergamo, Italy.
¹⁹ San Gerardo Hospital, Monza, Italy.
²⁰ Department of Medical Oncology, ASST Spedali Civili, Brescia, Italy.
²¹ Medical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
²² Department of Medical Oncology, Ospedale Santa Maria Delle Croci, Ravenna AUSL Romagna, Ravenna, Italy.
²³ Department of Medical Oncology, S. Croce E Carle Teaching Hospital, Cuneo, Italy.
²⁴ Medical Oncology, IRCCS Azienda Ospedaliera, Universitaria Di Bologna, Bologna, Italy.
²⁵ Department of Medical Oncology, IRCCS Istituto Romagnolo Per Lo Studio Dei Tumori (IRST) "Dino Amadori", Meldola, Italy.
²⁶ Oncology Unit, University Hospital of Modena, Modena Cancer Centre, Modena, Italy.
²⁷ Department of Epidemiology and Data Science, Data Science Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
²⁸ Biostatistics for Clinical Research Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
²⁹ Scientifc Directorate, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
³⁰ Department of Surgery, Division of HPB, General Surgery and Liver Transplantation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

No abstract available

Publication types

Published Erratum